Weight-loss drugs are back in the news, thanks to the emergence of a bidding war between industry heavyweights Novo Nordisk (NVO) and Pfizer (PFE) over obesity drug developer Metsera (MTSR), which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback